CC
ABBV icon

Cipher Capital’s AbbVie ABBV Stock Holding History

Cipher Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.34M Sell
7,335
-15,498
-68% -$2.67M 0.62% 21
2023
Q4 		$3.54M Buy
22,833
+12,561
+122% +$1.83M 1.15% 3
2023
Q3 		$1.53M Buy
10,272
+4,226
+70% +$620K 1.09% 8
2023
Q2 		$815K Buy
+6,046
New +$887K 0.14% 228

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cipher Capital's ABBV Position: Q1 2024 in Review

Cipher Capital reduced its AbbVie (ABBV) stake by 68% in Q1 2024, selling an estimated $2.67M and leaving 7,335 shares worth $1.34M. The position accounts for 0.62% of the portfolio, ranked #21.

Cipher Capital first reported a position in ABBV in Q2 2023 and has held it in 4 quarters since. The position peaked at $3.54M in Q4 2023. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Cipher Capital held 7,335 shares of AbbVie worth $1.34M as of Q1 2024.
  • Cipher Capital sold 15,498 AbbVie shares in Q1 2024, an estimated $2.67M.
  • AbbVie made up 0.62% of Cipher Capital's portfolio in Q1 2024, its #21 holding.
  • Cipher Capital first reported a position in AbbVie in Q2 2023 and has held it in 4 quarters since.
  • Cipher Capital's AbbVie position peaked at $3.54M in Q4 2023.
  • 3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.